Texas 2017 - 85th Regular

Texas Senate Bill SB1367 Latest Draft

Bill / Senate Committee Report Version Filed 02/02/2025

Download
.pdf .doc .html
                            By: Menéndez S.B. No. 1367
 (In the Senate - Filed March 6, 2017; March 16, 2017, read
 first time and referred to Committee on Higher Education;
 April 24, 2017, reported adversely, with favorable Committee
 Substitute by the following vote:  Yeas 7, Nays 0; April 24, 2017,
 sent to printer.)
Click here to see the committee vote
 COMMITTEE SUBSTITUTE FOR S.B. No. 1367 By:  Menéndez


 A BILL TO BE ENTITLED
 AN ACT
 relating to policies and training regarding the use of epinephrine
 auto-injectors by public institutions of higher education;
 providing immunity.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 38.202, Education Code, is amended by
 amending Subsections (a) and (b) and adding Subsection (e) to read
 as follows:
 (a)  The commissioner of state health services shall
 establish an advisory committee to examine and review the
 administration of epinephrine auto-injectors to a person
 experiencing an anaphylactic reaction on a campus of a school
 district, [or] an open-enrollment charter school, or an institution
 of higher education.
 (b)  The advisory committee shall be composed of members
 appointed by the commissioner of state health services.  In making
 appointments, the commissioner shall ensure that:
 (1)  a majority of the members are physicians with
 expertise in treating anaphylaxis, including physicians who
 specialize in the fields of pediatrics, allergies, asthma, and
 immunology; [and]
 (2)  at least one member is a registered nurse employed
 by a school district or open-enrollment charter school as a school
 nurse;
 (3)  at least one member is an employee of a general
 academic teaching institution; and
 (4)  at least one member is an employee of a public
 junior college or a public technical institute.
 (e)  In this section, "general academic teaching
 institution," "institution of higher education," "public junior
 college," and "public technical institute" have the meanings
 assigned by Section 61.003.
 SECTION 2.  Section 38.207, Education Code, is amended to
 read as follows:
 Sec. 38.207.  ADVISORY COMMITTEE:  DUTIES.  The advisory
 committee shall advise the commissioner of state health services
 on:
 (1)  the storage and maintenance of epinephrine
 auto-injectors on school campuses and campuses of institutions of
 higher education;
 (2)  the training of [school] personnel and [school]
 volunteers at schools and institutions of higher education in the
 administration of an epinephrine auto-injector; and
 (3)  a plan for one or more [school] personnel members
 or [school] volunteers of a school or an institution of higher
 education trained in the administration of an epinephrine
 auto-injector to be on each [school] campus of a school or an
 institution of higher education.
 SECTION 3.  Chapter 51, Education Code, is amended by adding
 Subchapter Y-1 to read as follows:
 SUBCHAPTER Y-1.  MAINTENANCE, STORAGE, ADMINISTRATION, AND
 DISPOSAL OF EPINEPHRINE AUTO-INJECTORS
 Sec. 51.881.  DEFINITIONS.  In this subchapter:
 (1)  "Advisory committee" means the committee
 established under Section 38.202.
 (2)  "Anaphylaxis" means a sudden, severe, and
 potentially life-threatening allergic reaction that occurs when a
 person is exposed to an allergen.
 (3)  "Campus" means an educational unit under the
 management and control of an institution of higher education and
 may include, in addition to the main campus, off-campus and
 secondary locations, such as branch campuses, teaching locations,
 and regional centers.
 (4)  "Epinephrine auto-injector" means a disposable
 medical drug delivery device that contains a premeasured single
 dose of epinephrine that is intended to be used to treat
 anaphylaxis.
 (5)  "Institution of higher education" has the meaning
 assigned by Section 61.003.
 (6)  "Personnel" means employees of an institution of
 higher education.
 (7)  "Physician" means a person who holds a license to
 practice medicine in this state.
 Sec. 51.882.  MAINTENANCE, STORAGE, ADMINISTRATION, AND
 DISPOSAL OF EPINEPHRINE AUTO-INJECTORS.  (a)  Each institution of
 higher education may adopt and implement a policy regarding the
 maintenance, storage, administration, and disposal of epinephrine
 auto-injectors on the institution's campus.
 (b)  If a policy is adopted under Subsection (a), the policy:
 (1)  must provide that personnel or volunteers who are
 authorized and trained may administer an epinephrine auto-injector
 to a person who is reasonably believed to be experiencing
 anaphylaxis on the institution's campus; and
 (2)  may provide that personnel or volunteers who are
 authorized and trained may administer an epinephrine auto-injector
 to a person who is reasonably believed to be experiencing
 anaphylaxis at an off-campus event or while in transit to or from an
 off-campus event sponsored by the institution of higher education.
 (c)  The commissioner of state health services with advice
 from the advisory committee shall adopt rules regarding the
 maintenance, storage, administration, and disposal of an
 epinephrine auto-injector on the campus  of an institution of
 higher education subject to a policy adopted under Subsection (a).
 The rules must establish:
 (1)  the number of epinephrine auto-injectors
 available at each campus;
 (2)  the process for each institution of higher
 education to check the inventory of epinephrine auto-injectors at
 regular intervals for expiration and replacement; and
 (3)  the amount of training required for personnel or
 volunteers to administer an epinephrine auto-injector.
 (d)  Each institution of higher education that adopts a
 policy under Subsection (a) must require that the institution's
 campuses have personnel or volunteers authorized and trained to
 administer an epinephrine auto-injector present.
 (e)  The supply of epinephrine auto-injectors at a campus
 must be stored in a secure location and be easily accessible to
 personnel or volunteers authorized and trained to administer an
 epinephrine auto-injector.
 Sec. 51.883.  REPORT ON ADMINISTERING EPINEPHRINE
 AUTO-INJECTOR.  (a)  Not later than the 10th business day after the
 date a personnel member or volunteer administers an epinephrine
 auto-injector in accordance with a policy adopted under Section
 51.882(a), the institution of higher education shall report the
 information required under Subsection (b) to:
 (1)  the physician who prescribed the epinephrine
 auto-injector; and
 (2)  the commissioner of state health services.
 (b)  The report required under this section must include the
 following information:
 (1)  the age of the person who received the
 administration of the epinephrine auto-injector;
 (2)  whether the person who received the administration
 of the epinephrine auto-injector was a student, a personnel member,
 or a visitor;
 (3)  the physical location where the epinephrine
 auto-injector was administered;
 (4)  the number of doses of epinephrine auto-injector
 administered;
 (5)  the title of the person who administered the
 epinephrine auto-injector; and
 (6)  any other information required by the commissioner
 of state health services.
 Sec. 51.884.  TRAINING. (a)  Each institution of higher
 education that adopts a policy under Section 51.882(a) is
 responsible for training personnel or volunteers in the
 administration of an epinephrine auto-injector.
 (b)  Training required under this section must:
 (1)  include information on:
 (A)  recognizing the signs and symptoms of
 anaphylaxis;
 (B)  administering an epinephrine auto-injector;
 (C)  implementing emergency procedures, if
 necessary, after administering an epinephrine auto-injector; and
 (D)  properly disposing of used or expired
 epinephrine auto-injectors; and
 (2)  be provided in a formal training session or
 through online education and be completed annually.
 (c)  Each institution of higher education that adopts a
 policy under Section 51.882(a) shall maintain records on the
 training required under this section.
 Sec. 51.885.  PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS.
 (a)  A physician may prescribe epinephrine auto-injectors in the
 name of an institution of higher education that adopts a policy
 under Section 51.882(a).  The physician shall provide the
 institution with a standing order for the administration of an
 epinephrine auto-injector to a person reasonably believed to be
 experiencing anaphylaxis.
 (b)  The standing order under Subsection (a) is not required
 to be patient-specific, and the epinephrine auto-injector may be
 administered to a person without an established physician-patient
 relationship.
 (c)  Notwithstanding any other provisions of law,
 supervision or delegation by a physician is considered adequate if
 the physician:
 (1)  periodically reviews the order; and
 (2)  is available through direct telecommunication as
 needed for consultation, assistance, and direction.
 (d)  An order issued under this section must contain:
 (1)  the name and signature of the prescribing
 physician;
 (2)  the name of the institution of higher education to
 which the order is issued;
 (3)  the quantity of epinephrine auto-injectors to be
 obtained and maintained under the order; and
 (4)  the date of issue.
 (e)  A pharmacist may dispense an epinephrine auto-injector
 to an institution of higher education without requiring the name or
 any other identifying information relating to the user.
 Sec. 51.886.  GIFTS, GRANTS, AND DONATIONS. An institution
 of higher education may accept gifts, grants, donations, and
 federal funds to implement this subchapter.
 Sec. 51.887.  RULES. Except as otherwise provided by this
 subchapter, the commissioner of state health services shall adopt
 rules necessary to implement this subchapter.
 Sec. 51.888.  IMMUNITY FROM LIABILITY. (a)  A person who in
 good faith takes, or fails to take, any action under this subchapter
 is immune from civil or criminal liability or disciplinary action
 resulting from that act or failure to act, including:
 (1)  issuing an order for epinephrine auto-injectors;
 (2)  supervising or delegating the administration of an
 epinephrine auto-injector;
 (3)  possessing an epinephrine auto-injector;
 (4)  maintaining an epinephrine auto-injector;
 (5)  storing an epinephrine auto-injector;
 (6)  disposing of an epinephrine auto-injector;
 (7)  prescribing an epinephrine auto-injector;
 (8)  dispensing an epinephrine auto-injector;
 (9)  administering, or assisting in administering, an
 epinephrine auto-injector;
 (10)  providing, or assisting in providing, training,
 consultation, or advice in the development, adoption, or
 implementation of policies, guidelines, rules, or plans; or
 (11)  undertaking any other act permitted or required
 under this subchapter.
 (b)  The immunity provided by Subsection (a) is in addition
 to other immunity or limitations of liability provided by law.
 (c)  Notwithstanding any other law, this subchapter does not
 create a civil, criminal, or administrative cause of action or
 liability or create a standard of care, obligation, or duty that
 provides the basis for a cause of action for an act or omission
 under this subchapter.
 (d)  An institution of higher education or a campus of an
 institution of higher education is immune from suit resulting from
 an act, or failure to act, under this subchapter, including an act
 or failure to act under related policies and procedures.
 (e)  A cause of action does not arise from an act or omission
 described by this section.
 SECTION 4.  This Act applies beginning with the 2018 spring
 semester.
 SECTION 5.  This Act takes effect September 1, 2017.
 * * * * *